Abstract
DURING the past decade it has become increasingly evident that although the over-all incidence of degenerative vascular disease increases with the duration of diabetes, patients under good control show significantly fewer complications than those who have been poorly controlled.1 2 3 4 Fully 70 per cent of the members of the American Diabetes Association subscribe to the concept of normoglycemia as a major objective of treatment, and another 23 per cent to the goal of aglycosuria.5 These objectives are not achieved in the majority of patients. Although statistics are difficult to obtain, reports from two large clinics indicate that only 13.5 per cent . . .